Government Launches Rs 5000 Crore Scheme to Boost Pharma Innovation

The Department of Pharmaceuticals will be supporting the research and innovation in pharma and medical technology, as the department has released an online portal for a scheme of Rs.5,000 crore. India is one of the major pharmaceutical m...

India Rises in Global Pharma as 'China Plus 1' Takes Hold

India’s pharmaceutical sector is seeing early benefits, as global drugmakers begin to shift a portion of their outsourcing arrangements from China to Indian firms, following the China+1 strategy. Major Contract Research and Manufacturing...

India's 1st Gender-Neutral HPV Shot Powers Serum's Cervavac Campaign

The Serum Institute of India (SII), the world's leading vaccine manufacturer by volume, launched Cervavac, India’s first indigenously manufactured gender-neutral quadrivalent HPV vaccine...

Biocon, NCSM Join Hands to Deliver Affordable Cancer Treatment

In a major milestone in equitable cancer treatment, Biocon Biologics partnered with the National Cancer Society of Malaysia (NCSM) to put into action a Patient Assistance Programme (PAP) in order to increase access to affordable, quality...

NIV Discovers Anti-Viral Breakthrough Against Chandipura Virus Threat

A major step in the direction of infectious disease research in India, Pune-based National Institute of Virology (NIV), under the Indian Council of Medical Research (ICMR), has found anti-viral drug Favipiravir as a potential candidate against Chandi

Glenmark Introduces Tevimbra in India for Advanced Cancer Care

In a significant milestone for the evolution of cancer care in India, Glenmark Pharmaceuticals announced the launch of Tevimbra (tislelizumab), an innovative immune-oncology drug of the Central Drugs Standard Control Organization (CDSCO)...

India Unleashes Rs. 5,000 Cr Innovation Fund to Lead Global Creation

India's pharma and MedTech industries await the change with the launch of the Rs. 5,000-crore Promotion of Research and Innovation in Pharma MedTech Sector (PRIP) scheme.

Novo Nordisk Plans Nationwide Launch of Wegovy in Indian Market

Danish pharmaceutical leader Novo Nordisk is targeting $1 billion (Rs 8,600 crore) in sales in India with its highly successful weight-loss medication Wegovy (semaglutide) within the next five to seven years. To achieve this goal, ET has learned that

Needle-free HIV vaccine study begins with Immuno Cure, PharmaJet

Immuno Cure BioTech, located in Hong Kong Science Park, has formed a partnership with PharmaJet to assess the safety and immunogenicity of ICVAX, Immuno Cure's HIV therapeutic DNA

ICMR-NIIH Develops World's First Rapid Test for Haemophilia A and VWD

The Indian Council of Medical Research’s National Institute of Immunohaematology (ICMR-NIIH) has developed the world’s first simple...

on the deck

Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.